e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Systemic and airway biomarkers in respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
L. C. Mutlu, M. Oran, S. Güzel, O. Avci, B. C. Yalçin, V. Küçükyalçin (Tekirdag, Turkey)
Source:
Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Session:
Systemic and airway biomarkers in respiratory diseases
Session type:
Thematic Poster Session
Number:
842
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. C. Mutlu, M. Oran, S. Güzel, O. Avci, B. C. Yalçin, V. Küçükyalçin (Tekirdag, Turkey). Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 842
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
Forced expiratory volume in one second (FEV
1
) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001
Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV
1
) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
FEF
25-75%
should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005
Is the forced expiratory volume in 6 seconds (FEV
6
) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients
Source: Eur Respir J 2001; 18: Suppl. 33, 13s
Year: 2001
Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up
Source: Eur Respir J 2016; 47: 742-750
Year: 2016
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations
Source: Eur Respir J 2012; 39: 290-296
Year: 2012
Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients
Source: Eur Respir J 2009; 34: 776
Year: 2009
Prediction of all cause mortality in a population sample is improved by using FEV
1
quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Comparison between peak expiratory flow rate (PEFR) and FEV1 in the monitoring of children suspected to asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 506s
Year: 2002
Does rapid decline predict poor prognosis?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007
Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
Forcede expiratory volume in six second in the spirometric diagnosis of COPD
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept